- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2398-8460
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lipid-based formulations in cosmeceuticals and biopharmaceuticals ; volume:4 ; number:1 ; day:6 ; month:5 ; year:2020 ; pages:1-10 ; date:12.2020
Biomedical dermatology ; 4, Heft 1 (6.5.2020), 1-10, 12.2020
- Urheber
-
Ahmad, Anas
Ahsan, Haseeb
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41702-020-00062-9
- URN
-
urn:nbn:de:101:1-2020063006225601789189
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahmad, Anas
- Ahsan, Haseeb
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipid-based depots : manufacturing, administration and interactions of protein drugs with lipid formulations
Intrinsic lipolysis rate for systematic design of lipid-based formulations
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured lipid carrier (NLC) formulations for topical application
Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Development of lipid based depot formulations using interferon-beta-1b as a model protein
In silico, in vitro, and in vivo evaluation of precipitation inhibitors in supersaturated lipid-based formulations of venetoclax
Amphotericin B lipid formulations and target-site penetration into human body fluids
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration
Lipid-based depots : manufacturing, administration and interactions of protein drugs with lipid formulations
Intrinsic lipolysis rate for systematic design of lipid-based formulations
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured lipid carrier (NLC) formulations for topical application
Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Development of lipid based depot formulations using interferon-beta-1b as a model protein
In silico, in vitro, and in vivo evaluation of precipitation inhibitors in supersaturated lipid-based formulations of venetoclax
Amphotericin B lipid formulations and target-site penetration into human body fluids
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration
Lipid-based depots : manufacturing, administration and interactions of protein drugs with lipid formulations
Intrinsic lipolysis rate for systematic design of lipid-based formulations
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured lipid carrier (NLC) formulations for topical application
Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Development of lipid based depot formulations using interferon-beta-1b as a model protein
In silico, in vitro, and in vivo evaluation of precipitation inhibitors in supersaturated lipid-based formulations of venetoclax
Amphotericin B lipid formulations and target-site penetration into human body fluids
Synthesis of enhanced lipid solubility of indomethacin derivatives for topical formulations